Listing as a PSO encourages providers to pool and compare outcomes data to determine treatment best practices without fear of litigation. Moreover, submitting outcomes data to a PSO does not require individual patient consent or prior IRB approval, making this a simple way for providers to assess and improve the quality of care they provide to their patients
West Lebanon, NH (PRWEB) December 16, 2009
M2S, Inc., a leading provider of clinical data and image management services, today announced that its component organization, Vascular Study Group Patient Safety Organization, LLC (VSG PSO), has been approved as a Patient Safety Organization (PSO) by the Agency of Healthcare Research and Quality, a division of the Department of Health and Human Services. Listing as a PSO offers providers a means to pool outcomes data for quality improvement purposes in a federally protected environment shielded from discovery in disciplinary proceedings.
M2S provides physicians, hospitals and other healthcare providers with the ability to improve practice standards through use of its Clinical Data Pathways platform. Pathways is a secure, web-based clinical data management solution that provides real-time access to risk-adjusted benchmarked reports and facilitates local, regional and national data collaboration, while providing the customer with complete control of their data.
"Listing as a PSO encourages providers to pool and compare outcomes data to determine treatment best practices without fear of litigation. Moreover, submitting outcomes data to a PSO does not require individual patient consent or prior IRB approval, making this a simple way for providers to assess and improve the quality of care they provide to their patients," stated M2S CEO, Wes Chapman. For publishing and research purposes, M2S has put in place best-in-class security and privacy policies to reduce obstacles traditionally associated with attaining IRB approval and patient consent.
M2S developed its Clinical Data Pathways system through partnering with the Vascular Study Group of New England (VSGNE) to advance its vascular quality improvement registry. The VSGNE quality improvement registry, formed in 2002, has prospectively collected data on more than 12,000 patients undergoing carotid endarterectomy, carotid stenting, lower extremity arterial bypass and open and endovascular repair of abdominal aortic aneurysms. It is the vision of both the VSGNE and M2S that the vascular quality improvement registry model will be replicated in other regions of the United States, facilitating widespread benchmarking and quality initiatives to improve patient outcomes.
About M2S, Inc.
M2S offers medical data and image management services across the healthcare continuum based on best-in-class technology and continuous quality improvement processes, including clinical data management solutions, clinical trials and advanced radiographic image analysis. All M2S services focus on increasing operational efficiency, reducing total cost and maintaining or enhancing clinical quality. M2S is the leading provider of AAA and TAA Treatment Planning using its Preview® Software/Services and its PEMS® (Patient Endovascular Management Services) registry for the vascular surgery field. For more information, visit http://www.m2s.com.